Author:
Li Fuhai,Wang Jingfeng,Song Yu,Shen Dongli,Zhao Yongchao,Li Chaofu,Fu Mingqiang,Wang Yanyan,Qi Baozheng,Han Xueting,Sun Aijun,Zhou Jingmin,Ge Junbo
Funder
National Natural Science Foundation of China
National Key Research and Development Program of China
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference55 articles.
1. Global public health burden of heart failure;Lund;Cardiac Failure Review,2017
2. Epidemiology and aetiology of heart failure;Ziaeian;Nat. Rev. Cardiol.,2016
3. Aragam KG, Chaffin M, Levinson RT, McDermott G, Choi SH, Shoemaker MB, et al. Phenotypic refinement of heart failure in a national biobank facilitates genetic discovery. Circulation. 2018.
4. A review of the current evidence for the use of angiotensin-receptor blockers in chronic heart failure;Erhardt;Int. J. Clin. Pract.,2005
5. Roig E, Perez-Villa F, Morales M, Jiménez W, Orús J, Heras M, et al. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure. Eur. Heart J. 2000;21:53–7.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献